top of page
brain.png

AI-Pharma.Capital 

Specialized Hybrid Investment Platform for the AI in Pharma Industry

Home

about us

AI-Pharma is a hybrid investment platform specifically focused on the AI in Pharma and Drug Discovery sectors, backed by seasoned professionals who have been active in both the investment banking and AI for Drug Discovery industries for years, long before the sector was recognized as a serious prospect by the overwhelming majority of investors, and some of whom made their first investments into the sector in 2014. The fund structures its portfolio based on sophisticated industry intelligence and comparative analytics, which are provided by the Pharma Division of Deep Knowledge Analytics, the world-leading source of market intelligence on the AI for Drug Discovery, Biomarker Discovery and Advanced R&D sectors. Deep Knowledge Analytics uses hundreds of quantitative and fact-based parameters to identify prospective investment targets for the fund by utilising multidimensional analytical frameworks as complex as the industry itself.

 

AI for Drug Discovery, Biomarker Development and Advanced R&D is considered by the majority of experts and analysts as one of the most prospective sectors in the Pharma industry in terms of its disruptive potential, capability to increase the efficiency and decrease costs of developing new drugs and improve the performance and profitability of leading Pharma corporations

About
db35502f9c.png

Provides Liquidity Similar to Hedge Funds Combined With Venture Fund Style Objectives

782830_euro_512x512.png

Invests in the Top 10% of Companies in the Longevity Industry

102649.png

Significantly De-Risks the Interests of Limited Partners and Portfolio

global-industry-icon-vector-7266209_edit

Bets on the Success of the Entire Industry, rather than  of Individual Companies

Our Team

OUR TEAM

dmitry_face_1x1-1-1024x1024.jpg

DMITRY KAMINSKIY

GENERAL PARTNER

Dmitry Kaminskiy is based in London. He is an experienced AI in Pharma industry investor and entrepreneur and the founder of Deep Knowledge Ventures and Aging Analytics Agency since 2014.

  • LinkedIn Social Icon
0.jpg

STEFAN HASCOET

MANAGING PARTNER

Stefan Hascoet is based in Geneva. He is a Capital Markets Professional with 15 years of experience in investment products, derivatives and non-recourse lending facilities.

  • LinkedIn Social Icon
лфеу.png

KATE BATZ

MANAGING PARTNER

Kate Batz is based in San Francisco. She is licensed to practice law in California and New York and has 20 years of experience as a Corporate Attorney.

  • LinkedIn Social Icon
image4.png

IHOR KENDIUKHOV

DEPUTY MANAGING PARTNER

Ihor Kendiukhov is based in Berlin. He is a finance quant, AI and deep tech professional and leads the Big Data and Algorithmic Analytics Departments at Deep Knowledge Group.

  • LinkedIn Social Icon
Contact Us
bottom of page